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ABSTRACT: In an effort to determine whether or not any characteristic hromosomal bnormalities 
exist in renal cancer, cytogenetic findings were correlated with tumor histology in nine cases 
of renal adenocarcinoma. Metaphase preparations adequate for analysis were obtained from 
cultures harvested between day 3 and day 21. Model chromosome number was diploid in 
three cases, hypodiploid in three, and hyperdiploid in the remaining three. One clear cell 
adenocarcinoma f iled to reveal any chromosomal bnormality. Two tumors, a tubular/pap- 
illary carcinoma and an acinar/papillary carcinima, showed the clonal abnormalities 
del(1)(p21),+2,+7,+8,+12,+13,+16,+17,-21 and t(2;lO)(q14-21;q26),+7q,+11q,-18, 
respectively. Interestingly, five of six clear cell tumors studied had clonal abnormalities af- 
fecting the short arm of chromosome #3 in the 3p12-21 region, and in the remaining case, 
of 15 karyotyped metaphases suitable for interpretation, one showed a deletion in 3p. These 
data indicate that clear cell carcinoma of the kidney may be associated with a nonrandom 
chromosomal abnormality involving the 3p12-14 region. 
INTRODUCTION 
Almost all human cancers, when studied appropriately, will show changes in chro- 
mosome structure or number [1, 2]. These findings take on added significance when 
it is noted that the chromosome breakpoints identified in human tumors frequently 
correlate with the location of cellular oncogenes [3]. There are few cytogenetic stud- 
ies of primary renal carcinomas. Cohen t al. described a family with herediatary 
renal carcinoma nd a constitutional balanced translocation between chromosomes 
#3 and #8: t(3;8)(p21;q24) [4]. Subsequently, high resolution G-banding analysis 
documented that the chromosome #3 breakpoint occured at 3p14.2, rather than 
3p21 [5]. Another familial renal carcinoma was reported with a t(3;11)(p13-14;p15) 
limited only to tumor cells [6]. Wang et al. described abnormalities of chromosomes 
#3 and #6 in fresh renal tumors and cell lines [7]. Recently, Yoshida et al. de- 
scribed rearrangements involving chromosome #3 in eight of 12 nonfamilial renal 
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carcinomas [8]. Deletion of 3p was noted in four cases, translocations involving 
chromosome #3 in four cases, and an i(3p) in one case. Additional clonal changes 
were noted in these and in two other tumors. In two additional sporadic renal car- 
cinomas studied, clonal abnormalities were noted, but none affected the 3p13-14 
region [9, 10]. In an effort to confirm these reports and see if any additional chro- 
mosomal abnormalities might exist in these tumors, cytogenetic findings were cor- 
related with tumor histology in nine cases of primary, nonfamilial renal adenocar- 
cinoma. 
MATERIALS AND METHODS 
Primary tumor samples were obtained at the time of surgery from patients with 
either local or metastatic renal carcinoma. Tumor samples were transferred imme- 
diately to the laboratory, where they were minced and then disaggregated either 
mechanically or enzymatically. In the latter cases, tumor samples were exposed to 
either warm trypsin (0.025%) or collagenase (0.1%), hyaluronidase (0.01%) and 
DNase (0.002%) [11]. The cells were washed three times with Hank's balanced salt 
solution or RPMI 1640 medium. Aliquots of tumor cells were transferred to 25-cm 2
plastic culture flasks and incubated in RPMI 1640 medium supplemented with 15% 
fetal calf serum, !% glutamine, and antibiotics (penicil l in 100 p.m/ml and strepto- 
mycin 100 p~g/ml)in an atmosphere of 5% CO2. Medium was changed after 24-48 
hours and dead or nonattached cells were removed. Proliferating cultures were ex- 
posed to colcemid (0.01 to 0.02 ~g/ml) for 3-12 hours depending on the mitotic 
Figure 1 Partial karyotype of five clear cell adenocarcinomas with clonal abnormalities at 
the 3p13-14 region. Cases 2 and 3 show del(3)(p13), whereas, case 4 shows a deletion occur- 
ring more proximally, del(3)(p12). Cases 1 and 5 show dir ins(3)(p13p21). 
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activity of the culture. The cultered cells were detached using 0.025% trypsin with 
EDTA. Cells were then treated with 0.075 M KC1, fixed with methanol/acetic a id 
(3:1), and applied to standard, glass microscope slides. Chromosomes were ana- 
lyzed using either Q- or G-banding, as previously described [12]. Metaphase chro- 
mosomes were analyzed and modal number was recorded [13]. The clinical stage 
along with the particular histologic type of tumor was recorded in each case. 
RESULTS 
Metaphase preparations adequate for interpretation were obtained from nine renal 
adenocarcinomas after 3-21 days of culture (Table 1). The tumors were removed 
from four women and five men, aged 38-73 years. All tumor stages were repre- 
sented, but histology varied. Modal chromosome number was 46 in three cases, 
hypodiploid in three, and hyperdiploid in the remaining three cases. Several inter- 
esting cytogenetic abnormalities were noted. The most common clonal abnormality 
involved the short arm of chromosome #3. Five clear cell carcinomas howed 
clonal abnormalities in this region (Fig. 1). These abnormalities seemed to be local- 
ized to the 3p12-21 region and included del(3)(p13) in two cases, dir ins(3)(p13p21) 
in two cases, and del(3)(p12) in one case. The origin of the inserted segments could 
not be determined with certainty. An additional clear cell carcinoma had 15 meta- 
phases adequate for interpretation a d in one del(3)(p13) was noted. One renal ad- 
enocarcinoma (case 7) showed no chromosomal abnormalities. Case 8 had a tubular/ 
papillary carcinoma that contained el(1)(p21-*pter) plus either addition or loss of 




number Sex/Age (y r )  Histology Stage Mode Range Karyotype 
1 M/64 Clear cell IV 45 42-78 45,XY,dir dup(1)(q12-~ 
q44),dir ins(3) 
(p13p21),- 15 
2 F/52 Clear cell I 44 36-83 44,X, - Xdel(3)(p13), - 9 
3 F/41 Clear cell IV 63 38-79 63,XX ÷ X,del(3)(p13), 
+1,÷2,÷4,÷9,÷10, 
÷ 12,+ 13,÷ 14,÷ 15, 
+ 16,+ 19,÷ 21,+ 22, 
÷ 7q +,11q + ,i(8q) 
4 F/73 Clear cell IV 46 43-89 46,XX,del(3)(p12) 
5 F/54 Clear cell III 49 32-72 49,XX,dir ins(3) 
(p13p21),÷ 2,+ 7, 
÷16 
6 M/61 Clear cell IV 46 32-83 46,XY,del(3)(p13) a 
7 M/38 Clear cell/ I 46 33-47 46,XY 
papillary 
8 M/68  Tubular/papillary II 52 29-56 52,XY,del(1)(p21), 





9 M/58  Acinar/papillary II 45 41-87 
°This abnormality was seen in only one of 15 metaphases karyotyped, therefore, we cannot establish its clonal nature. 
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Figure 2 A tubular/papillary adenocarcinoma (c se 8). The karyotype shown is not com- 
pletely representative of the c|onal karyotype, which possesses a sex chromosome constitution 
of XY and fails to show consistent gain of chromosome #21. 
several chromosomes (Fig. 2). Case 9 had a papillary tumor that showed t(2;10)(q14- 
21;q26) and 7q÷, 11q÷ abnormalities (Fig. 3). Additional clonal abnormalities 
were noted in several of the tumors. 
DISCUSSION 
The consistency of chromosome #3 rearrangements in cancers of the kidney sug- 
gested in previous reports is confirmed in the present study, where six of nine 
tumors displayed abnormalities at region 3p. These were demonstrated to be clonal 
in five cases, whereas, in the sixth case only a single cell with a 3p abnormality 
was encountered. Four of the five tumors with clonal abnormalities at chromosome 
region 3p12-14 possessed few additional cytogenetic hanges. This strongly sug- 
gests that rearrangment a  this site may play an early and perhaps critical role in 
tumor induction or progression. We also found that #3 abnormalities were confined 
to tumors with a clear cell histology. It is not clear from several previous reports if 
abnormalities of chromosome #3 occurred in any other histologic subtype. In the 
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Figure 3 An acinar/papillary adenocarcinoma (case 9) showing t(2;10)(q14-21;q26), 
7q÷ ,11q÷. 
present study, the rarer papi l lary adenocarcinomas did not display abnormalities in
this region. One clear cell adenocarcinoma f iled to show any chromosome abnor- 
malities. The metaphases examined in this case may have been derived from sur- 
rounding normal kidney cells that proliferated in culture. It may also be that a 
submicroscopic abnormality was present, but undetectable by the standard banding 
techniques used. 
Several human tumors including small cell lung carcinomas, salivary gland tu- 
mors, rhabdomyosarcomas, nd ovarian carcinomas manifest chromosomal abnor- 
malities at the 3p13-14 region. This suggests that this chromosomal region may 
contain a gene or genes whose deletion or deregulation is important in the induc- 
tion or growth of these tumors [14-17]. The nature of such a gene remains to be 
determined. The c-raf oncogene has been mapped more distally along chromosome 
region 3p and expression of this gene has not been studied in renal cancers [18]. 
Drabkin et al. recently described translocation of c-myc to the 3p14.2 breakpoint in 
a case of hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) 
chromosomal translocation [19]. Only one tumor in the present report (case 3) 
showed detectable abnormalit ies of chromosome #8 and this was i(8q). A possible 
c°ras related gene has been localized to the 3p12-14 region in human germ line 
chromosomes [20]. No mutations of c-Ki°ras oncogene were reported in a study of 
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ten human renal carcinomas u ing restriction fragment length polymorphisms for 
this gene [21]. Trent et al. studied several rhabdomyosarcomas with abnormalities 
at region 3p13-14 and were unable to find a H-ras related sequence in this region. 
In addition, they also failed to detect structural alterations or amplification of the 
c-Ha-ras or N-ras genes [16]. 
A certain degree of concordance exists between fragile sites, oncogene locations, 
and chromosomal breakpoints found in a variety of solid and hemopoeitic neo- 
plasms [22]. The 3p13-14 region has been reported to be a common fragile site [23]. 
Interestingly, Pathak and Goodacre have described a patient with a renal carcinoma 
that showed a t(3;8). The patient did not have a constitutional translocation, but 
his peripheral lymphocytes showed an increased xpression of the fragile site at the 
3p13-14 region after treatment with FUdR and caffeine, suggesting that somatic 
expression of a constitutional fragile site may lead to a clonal karyotypic abnormal- 
ity in the tumor [24]. 
Balanced chromosomal translocations involving oncogene locations are common 
in hemopoetic neoplasms [25]. These rearrangements are thought o lead to onco- 
gene activation and neoplastic transformation. Alternatively, so idtumors including 
the renal adenocarcinomas in the present study rarely show balanced translocations 
and such tumors are more frequently characterized by either nonreciprocal chro- 
mosome translocations or deletions [26]. Certain solid tumors may be a product of 
gene loss with activation of a tumor-promoting recessive allele. Retinohlastomas 
and Wilms' tumors, both, are thought o arise in such a fashion [27-29]. Whether 
or not such a gene exists at the 3p12-14 site and is responsible for the induction of 
renal carcinoma nd other solid tumors with similar chromosomal bnormalities 
remains to be determined. 
Our data confirm that renal adenocarcinoma is associated with a nonrandom 
chromosomal bnormality at the 3p12-14 region. In the present study, this abnor- 
mality was confined to tumors with a clear cell histology. Because several solid 
tumors possess imilar abnormalities, continued study of this region may provide 
important insights into the genetic mechanisms of cancer induction or mainte- 
nance. 
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